Javed Ali
Pharmacology, Toxicology and Pharmaceutics · University of Michigan
Publications
488
Citations
23,324
Est. group size
—
Recurring co-author estimate
Active years
30
Publishing since 1997
Typically publishes in teams of ~6 · 14% small-team papers (≤3 authors) · across 116 venues
- Bioanalytical RP‐HPLC Method Development and Validation for Simultaneous Estimation of Temozolomide and Resveratrol: A Pharmacokinetic Analysis in Rat Plasma and Brain
Biomedical Chromatography · 2026
- Advanced nanomedicine-based strategies for glioblastoma management: Targeted delivery, photodynamic therapy, and theranostic integration
Journal of Drug Delivery Science and Technology · 2026
- A narrative review on nanogel-based topical delivery of chemotherapeutic and phytoagents for non- melanoma skin cancer treatment
Therapeutic Delivery · 2026
- Explicating the transformative role of artificial intelligence in designing targeted nanomedicine
Expert Opinion on Drug Delivery · 2025
- Explicit analysis of <i>in vivo</i> , meterological and statistical hurdles in successful clinical translation of targeted nanomedicines and plausible remedial strategies
Expert Opinion on Drug Delivery · 2025
- Nose to brain delivery of nanostructured lipid carriers loaded with rivastigmine and nilotinib for treating Alzheimer’s disease: preparation, cell line study, and in vivo evaluation
Discover Nano · 2025
- Development and Preclinical Assessment of a Palbociclib Nanostructured Lipid Carrier for Potential Breast Cancer Management
Molecular Pharmaceutics · 2025
- Formulation and Evaluation of Lipid Nanogel Loaded with Quercetin and Curcumin for Improvement of Topical Bioavailability
Indian Journal of Pharmaceutical Education and Research · 2025
- Transforming pulmonary health care: the role of artificial intelligence in diagnosis and treatment
Expert Review of Respiratory Medicine · 2025
- Receptor-mediated nose-to-brain delivery of drug combination-loaded polymeric nanocarriers for the treatment of glioblastoma- current progress and future perspectives part I: receptor-mediated nose-to-brain delivery approaches for glioblastoma
Expert Opinion on Drug Delivery · 2025
- Synergistic anti-breast cancer activity of simvastatin and thymoquinone encapsulated in nanostructured lipid carriers for enhanced therapeutic outcomes
Journal of Microencapsulation · 2025
- A study of cognitive function, quality of sleep, and Stroop effect among adolescent girls with premenstrual syndrome
Panacea Journal of Medical Sciences · 2025
- Development and Characterization of Oral Efavirenz-Loaded Nanostructured Lipid Carriers and Their Optimization with Box–Behnken Design Approach for the Neurological Disorder
Assay and Drug Development Technologies · 2025
- Antimicrobial Peptides as Biomacromolecular Therapeutics against Antimicrobial Resistance: Structural Insights and Mechanistic Advances
International Journal of Peptide Research and Therapeutics · 2025
- Co-Delivery of Temozolomide and Quercetin via Nanoemulsion for Glioblastoma Therapy: From In-Silico to In-Vivo Evaluation
Journal of Cluster Science · 2025
- Elsevier eBooks×23
- Journal of Drug Delivery Science and Technology×17
- Expert Opinion on Drug Delivery×10
- Current Pharmaceutical Design×10
- Drug Delivery×6
- Clairissa D. Corpstein
Pharmacology, Toxicology and Pharmaceutics · Purdue University West Lafayette
- Andrew Otte
Pharmacology, Toxicology and Pharmaceutics · Purdue University West Lafayette
- Kurt D. Ristroph
Pharmacology, Toxicology and Pharmaceutics · Purdue University West Lafayette
- Rose Ackermann
Pharmacology, Toxicology and Pharmaceutics · University of Michigan
- Steven P. Schwendeman
Pharmacology, Toxicology and Pharmaceutics · University of Michigan
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 25, 2026.
Claim or correct this profile